Telehealth Will Drive The Bruxism Treatment Market Owing To Enhanced Access To Care

The bruxism treatment market involves products and procedures that diagnose and treat tooth grinding and associated symptoms during sleep. Some common treatment options include mouth guards, Botox, medical devices, and prescription drugs. Nighttime teeth grinding, also known as bruxism, can lead to excessive tooth wear, headaches, and jaw pain over time if left untreated.

The global bruxism treatment market is estimated to be valued at US$ 1,403.76 billion in 2024 and is expected to exhibit a CAGR of 11% over the forecast period of 2024-2030. Key factors such as the increasing workload and stress levels of people have contributed to the rising prevalence of bruxism worldwide. Advancements in telehealth platforms have enhanced access to bruxism care and remote diagnostics, thereby supporting market growth.

Key Takeaways
- Key players operating in the bruxism treatment market include Siemens AG, Cisco Systems Inc., IBM Corporation, Schneider Electric SE, General Electric Company, Honeywell International Inc., Huawei Technologies Co. Ltd., ABB Ltd., Hitachi Ltd., Microsoft Corporation, Oracle Corporation, Johnson Controls International plc, Black & Veatch Holding Company, Bentley Systems, Incorporated, SAP SE.
- Growing popularity of oral appliances and botox treatment is expected to drive the demand for bruxism treatment products over the forecast period.
- Continuous development of advanced medical devices for accurate diagnosis and minimally invasive procedures are expanding treatment capabilities.

Market Trends
- Increased adoption of telehealth and remote patient monitoring devices allow clinicians to efficiently diagnose and monitor bruxism cases from a distance.
- Integration of artificial intelligence and machine learning capabilities in bruxism diagnosis and treatment planning tools is enhancing clinical outcomes.

Market Opportunities
- Untapped growth potential in developing nations due to increasing medical expenditures and infiltration of private healthcare insurance.
- Launch of home healthcare devices and do-it-yourself bruxism treatment products is slated to augment market expansion through improved accessibility of care.

Impact of COVID-19 on Bruxism Treatment Market

The COVID-19 pandemic has significantly impacted the growth of the bruxism treatment market. During the initial lockdown phases declared by various countries worldwide, the market witnessed a decline due to restrictions on travel and limited access to dental clinics for bruxism diagnosis and treatment. However, with the resumption of dental services post relaxation in lockdown restrictions, the market has started recovering.

Pre-COVID, the growth in the Bruxism Treatment Market Share  was driven by the increasing prevalence of bruxism disorder mostly owing to rising levels of stress. Various treatment options such as mouth guards, splints, occlusal splints, and Botox injections were gaining popularity. However, during the peak of the pandemic, people avoided visiting dental clinics fearing exposure to the virus. This led to delay or postponed bruxism treatments.

Post-COVID, the demand has been recovering steadily as dental clinics adapt to new safety protocols and people regain confidence in seeking dental care. The market players are focusing on tele-dentistry and online consultations to diagnose and recommend treatment options to patients from the safety of their homes. Large companies are investing in R&D to develop home care products for bruxism management. With vaccination drives in progress globally, the market is expected to regain pre-pandemic growth rate in the coming years. However, future waves of infections might continue posing challenges.

In terms of value, North America holds the largest share in the bruxism treatment market owing to the growing prevalence of bruxism and rising dental expenditure in the region. Within North America, the United States accounts for the major share due to favorable reimbursement policies and healthcare infrastructure. Europe is another prominent regional market driven by increasing demand for splints and mouth guards to prevent premature tooth wear.

Asia Pacific is recognized as the fastest growing regional market for bruxism treatment. Factors such as the rising number of bruxism cases attributed to high levels of occupational and personal stress are driving the growth. Countries like China and India with their large population bases offer significant opportunities. Furthermore, growing medical tourism in Asia for affordable dental care treatments will support market expansion over the forecast period.

For more insights, read-https://www.newsstatix.com/bruxism-treatment-market-trends-size-and-share-analysis/